These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35056077)

  • 21. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inclusion complexes of cefuroxime axetil with β-cyclodextrin: Physicochemical characterization, molecular modeling and effect of l-arginine on complexation.
    Sapte S; Pore Y
    J Pharm Anal; 2016 Oct; 6(5):300-306. PubMed ID: 29403996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
    Patel R; Patel M
    Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-Depth Study of Cyclodextrin Complexation with Carotenoids toward the Formation of Enhanced Delivery Systems.
    Clercq S; Temelli F; Badens E
    Mol Pharm; 2021 Apr; 18(4):1720-1729. PubMed ID: 33656347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancer.
    Vangara KK; Ali HI; Lu D; Liu JL; Kolluru S; Palakurthi S
    AAPS PharmSciTech; 2014 Apr; 15(2):472-82. PubMed ID: 24477982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation, Characterization, and In Vitro Evaluation of Inclusion Complexes Formed between
    Tachikawa R; Saito H; Moteki H; Kimura M; Kitagishi H; Arce F; See GL; Tanikawa T; Inoue Y
    ACS Omega; 2022 Sep; 7(35):31233-31245. PubMed ID: 36092555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state.
    Mura P; Zerrouk N; Faucci M; Maestrelli F; Chemtob C
    Eur J Pharm Biopharm; 2002 Sep; 54(2):181-91. PubMed ID: 12191690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. gammaCD/HPgammaCD: synergistic solubilization.
    Jansook P; Loftsson T
    Int J Pharm; 2008 Nov; 363(1-2):217-9. PubMed ID: 18691643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Cellular Uptake Of Phenamil Through Inclusion Complex With Histidine Functionalized β-Cyclodextrin As Penetrative Osteoinductive Agent.
    Jahed V; Vasheghani-Farahani E; Bagheri F; Zarrabi A; Fink T; Lambertsen Larsen K
    Int J Nanomedicine; 2019; 14():8221-8234. PubMed ID: 31632029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of pioglitazone cyclodextrin inclusion complexes.
    Pandit V; Gorantla R; Devi K; Pai R; Sarasija S
    J Young Pharm; 2011 Oct; 3(4):267-74. PubMed ID: 22224032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate.
    Orienti I; Cerchiara T; Zecchi V; Arias Blanco MJ; Gines JM; Moyano JR; Rabasco Alvarez AM
    Int J Pharm; 1999 Nov; 190(2):139-53. PubMed ID: 10547454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental and Computational Investigation of Clustering Behavior of Cyclodextrin-Perfluorocarbon Inclusion Complexes as Effective Histotripsy Agents.
    Kaymaz B; Mustafa W; Hall S; Vlaisavljevich E; Sensoy O; Yuksel Durmaz Y
    Mol Pharm; 2022 Aug; 19(8):2907-2921. PubMed ID: 35839291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ternary system of sultamicillin tosylate with hydroxypropyl-β-cyclodextrin and L-arginine: susceptibility against methicillin-resistant
    Bolibol M; Guzman G; De Guzman LM
    Ther Deliv; 2022 Dec; 13(12):561-575. PubMed ID: 36861310
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.
    Ai F; Ma Y; Wang J; Li Y
    Iran J Pharm Res; 2014; 13(4):1115-23. PubMed ID: 25587299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.
    Babu RJ; Pandit JK
    Int J Pharm; 2004 Mar; 271(1-2):155-65. PubMed ID: 15129982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
    Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
    AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.